SEC Form D · Amendment · filed October 3, 2013
Stellar Biotechnologies, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Mary C. Brisson · Ventura, CAExecHerbert S. Chow · San Diego, CAExecFrank R. Oakes · Port Hueneme, CAExec · DirectorDaniel E. Morse · Santa Barbara, CADirectorGregory T. Baxter · Palo Alto, CADirectorScott Davis · Port Moody, British Columbia, CanadaExecMayank D. Sampat · Westlake Village, CADirectorDavid L. Hill · Hermosa Beach, CADirectorM. C. Shepherd · Toronto, Ontario, CanadaExec · DirectorBrian Ferko · Wayne, PADirectorPhilip A. Mcneill · Chevy Chase, MDExecJavier E. Aguirre · Chevy Chase, MDExecG. C. Williams, Iii · Chevy Chase, MDExecPeter M. Karmin · Chicago, ILDirectorJon "Kip" Hunter · Carlsbad, CADirectorRowland Hanson · Carlsbad, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗